Associated Papers
Differential transcript level of ANKRD26 and clinical phenotype among the ANKRD26 variants in the Japanese registry for congenital thrombocytopenia.
Sakamoto A et al.
British Journal of Haematology, 2025
Analysis of clinical characteristics and treatment efficacy in two pediatric cases of ANKRD26-related thrombocytopenia.
Pang C et al.
Platelets, 2023
Prevalence and natural history of variants in the ANKRD26 gene: a short review and update of reported cases.
Vyas H et al.
Platelets, 2022
ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms.
Sullivan MJ et al.
Current Hematologic Malignancy Reports, 2022
Relation between mutations in the 5' UTR of ANKRD26 gene and inherited thrombocytopenia with predisposition to myeloid malignancies. An Egyptian study.
Zidan NI et al.
Platelets, 2021
Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript.
Wahlster L et al.
The Journal of Experimental Medicine, 2021
Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26-related Thrombocytopenia and MYH9-related diseases.
Balduini A et al.
European Journal of Medical Genetics, 2018
5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia.
Marconi C et al.
Journal of Hematology & Oncology, 2017
Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.
Bluteau D et al.
The Journal of Clinical Investigation, 2014
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia.
Necchi V et al.
Thrombosis and Haemostasis, 2013
Select a paper to view details